Featured in New TherapeuticsNew Therapeutics News & ResearchFDA Approves Wezlana for Multiple Inflammatory DiseasesApproval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patientsBy Lori Solomon (HealthDay News) | November 02, 2023